A Randomized Double-Blind Study to Assess the Skin Irritation and Sensitization Potential of Once-Weekly Corplex Donepezil Transdermal Delivery System

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 14 Sep 2023

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

12 Sep 2023 According to a Corium Media Release, data from this study will be published in Alzheimer's Disease and Associated Disorders journal he October-December 2023 issue.
12 Sep 2023 Results presented in a Corium Media Release.
27 Apr 2023 Results assessing the skin irritation and sensitization potential of once-weekly 5-mg/d donepezil transdermal delivery system, presented at the 75th Annual Meeting of the American Academy of Neurology 2023.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com